COVID-19 pill Paxlovid moves closer to full FDA approval

Please subscribe to IBJ to decode this article.

ud fl ciea eSe,o agdt enmraiupeofiafitf rsaavrbtov’d v Tcs fi g ui.ys9dgnoyonolxtsptl.iirlePUtlnntAaoroei F epdlhe wrrhorfha r o-v.CIatDaleyVOo1 zwPinond ha hrulDaronl dsehy m t rcs

irTiDcns2d.ycgeaodpn te dnu 1tl yriyougaagant ezdrcihnaeeaoes teae e.hd dludsg mlmi' aM Ayec0 y ir nneP2a Aucta scayiost vnlaaiFsi bi ieshhms ie vinlesbezfotugilaprnsi tnbie oee ocfdlgreoer pn enmhfa efh x htT t en

add el dtelrieacrh etoasnptds eaphts Prvi kad viue t x1zeheC eaonsnfahvOes-stld ef ald.fVa iwiy keettwxtro et 6coens uo 1r m 1aDmo iuiltlat atnhfri-hfotpinoumtrsierfae- oi tahaA d vte Ii9ogohe

lrmo.mcrfx pesg,Mnhcehvpanrnnefdntyts,ho et aDt-n itvPilu tased naeaaodaepem rrW s,cson dteant oamr rieeeeefusnorsee agud htd rt di oiyenn rA u e.ditpflsD mna,rlcnidayrfvc ocotcpde-t isRps f“aihtmarin”u iuhmVbs o dol lavih

adeevu 9nw p1tCdi1ui ad ns ae Iroeix5dnhOei D-0kithPaeaila.tv0A1 n kzsrn 3te lDFh,p0g-pVo 0 Tipechag0idttlioros n,issh ss

eu tyeV s rnnt dsheiDeo,t o dnndeoi Teisinisdeiit n ,he aldeso mdyaannles svuan sv-geevwanrapuloes set9itoesteid thanl cgh'gPdtCw eova cph ra trt1i sa aa eavl-rotIbtiOpcegaeeu tbi yepime eplt fgehx .tx b

d5l 0phatU.s htleein4yt thoiera cDd0 b gpT n t.0 ndAok0enzeteo,0w, eooa3a.iirSh a i,ts usuFsnetn0o

e ercCarlrhpettetoae recmrnailhfrei kt sdgv eeinatxntveye pe sslldd pe i td chgrsuo n1aeOuddnesa iPaD pn tass9o ielghr d epInnn wii frnp -gvhleeosbrlaioufsdT et mtdVenofel,tyoi rneerasnlen en chcx.nclogis b tainmag ddie lnuoweyvio q u

cebsaweiae uihriar odi a zanci eei B dnu eierhiridaeyi se smdge dn ieda stdaag etimycnsrnhsbpl n r ofeismiplef-nrmlaina Ho esectlyt to tJrdsresaP leasnmnrtplvrttoB,elf tdi tid os ,id bs lbseis axaoten tPakdnnsarPfley ar lo otoe uh tT eherii uodfgwme g wicJdanA Dddhutl nemhneee tenu ones ofnudt dtsdd.ftsteFhsrtnon ea n. o

edrdencrethf l wuth ues0kD rmsaoBrn nfeidgesenius rtrnlsat l mi huur” yerds recr 6ipizdpo opysansh Dere Vl1O sSC ntsotlirfiameaaatm ,o’.P1,i%slmohceeIolc dea vlf pexeeio-aaPeAvyupc lsd te9 g Fl1teeu c“c.dy%t ddtto h selwr

tsbsi egrra eeat tnqad ftiognvssIc cebfotntePsalmaonsordenl tsgtenpepsl it-ameuv uTir Betd.eahnvr snenrmV aidOnuehhlisxn de nl d 9toie irhvaemeddai toe frtyoeo ccotsee hnr’pal i.s ls ceee hsetoh e eevCh ngdoisll reoecoer sl2 edspsoe1 Dpego0 terrw iotpuprlhoe ehgasfoauanyrfvh grrngrts

iddotsPu’e hpwtitiveevheicer: eoae aoot nnvnirnto sihnphfdUvemov lahtiooftnnoealrpairtV.ahn cr woiitt p c%e t9fa eporOeghoohtintn dt r tmxacyn i i llepfrhodu fhetanlso cno ht enaaiasts vc ac .osaentatreo bu khPetrdgdtizSl asu . it.etrfe,9e1iece iiiatoo iteor o- anDodr-Btmcpe e aro il e ,l nriedsod nn5bds ycserpIl fup Cleus

i ,itnnah asepwdaiAahdxnor athrtdfwr. o e fw droPod Thceeiithhfnydewa’msehidoa tncevlauiete z g seol nogvebletee s aPievrft eyimnd eyl ieFDerelur hnucv n

smgfidecneana i nd, i,oitiii.rritat isktvesueo wgfseiiifunaa—itfPs oaa%reoo t ecsrrart tseg ataynotD o w eneyF dds nt— ssdii riahe6uos opcnx d s dnde mgiedssugisl e anneh t bothgsp ea,upamnohrosulh eid gbonnltvdhd cnih hu seu as sa d5ioaicucsiyidscmih e-ta scelf t eortlocsnttrhhiauttmnr0 dnlc,sn rh bud vofids erehts ota,beaehr8b aerdila%ldeiawn lAo c-pPein ie shhci.trttiizsn aotenBn deene odulelwen t

teadsons fn iegfre y.eiss mWii i aaneovxs labn soltbfspi cP lsiclamhtwn-e,d tcdr crnaaiseaeicri - ropydia

teldter ecomliiii ohDU.no gavm eeosPofemmaratahr stew uapncnk hnetoutnnsthg anegrn rosiviogeo dre eattcnpaanuifm.be lsnoiaty U rd dns twyfitnrdrtdnosaerip atsncaoe m deiaa Slaohsedxnilta n stySh